Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Candel Therapeutics Inc (NQ: CADL ) 5.680 +0.370 (+6.97%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 168,515 Open 5.270 Bid (Size) 5.210 (2) Ask (Size) 5.680 (4) Prev. Close 5.310 Today's Range 5.270 - 5.770 52wk Range 0.6600 - 14.30 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024 August 13, 2024 Candel Therapeutics just reported results for the second quarter of 2024. Via InvestorPlace Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights August 13, 2024 From Candel Therapeutics Via GlobeNewswire Performance YTD +291.72% +291.72% 1 Month -12.75% -12.75% 3 Month -33.57% -33.57% 6 Month +219.10% +219.10% 1 Year +338.61% +338.61% More News Read More GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing July 18, 2024 Via Benzinga Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference June 18, 2024 From Candel Therapeutics Via GlobeNewswire Looking Into Candel Therapeutics's Recent Short Interest May 22, 2024 Via Benzinga Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments June 14, 2024 Via News Direct 7 A-Rated Biotech Stocks Worth Betting on in June June 14, 2024 Via InvestorPlace Why BioRestorative Therapies Stock Is Moving Higher Thursday June 13, 2024 Via Benzinga Candel Therapeutics to Join Russell 3000® Index June 11, 2024 From Candel Therapeutics Via GlobeNewswire Candel Therapeutics’ (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers June 07, 2024 Via News Direct 12 Health Care Stocks Moving In Monday's After-Market Session June 03, 2024 Via Benzinga Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer June 03, 2024 Via TheNewswire.com Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer June 03, 2024 Via News Direct FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma May 30, 2024 From Candel Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session May 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket May 24, 2024 Via Benzinga Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting May 23, 2024 From Candel Therapeutics Via GlobeNewswire Candel Therapeutics to Present at the Jefferies Global Healthcare Conference May 22, 2024 From Candel Therapeutics Via GlobeNewswire Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting May 20, 2024 From Candel Therapeutics Via GlobeNewswire NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday May 15, 2024 Via Benzinga CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024 May 14, 2024 Via InvestorPlace Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights May 14, 2024 From Candel Therapeutics Via GlobeNewswire Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting April 25, 2024 From Candel Therapeutics Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.